Atypical angiopoietin-like protein that regulates ANGPTL3

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 48, 2012, Pages 19751-19756

  Quagliarini, Fabiana ^a   Wang, Yan ^a,b   Kozlitina, Julia ^a   Grishin, Nick V ^a,b   Hyde, Rhonda ^a   Boerwinkle, Eric ^c   Valenzuela, David M ^d   Murphy, Andrew J ^d   Cohen, Jonathan C ^a   Hobbs, Helen H ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d REGENERON PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN 3; ANGIOPOIETIN 8; GUANINE NUCLEOTIDE EXCHANGE FACTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOSE DERIVED STEM CELL; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; FEEDING; HUMAN; HYPERTRIGLYCERIDEMIA; IMMUNOPRECIPITATION; INTRON; LIVER; LIVER CELL; MOUSE; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; TRIACYLGLYCEROL BLOOD LEVEL;

AMINO ACID SEQUENCE; ANGIOPOIETINS; ANIMALS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HYPERTRIGLYCERIDEMIA; INTRONS; LIVER; MICE; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, AMINO ACID; TRIGLYCERIDES;

MUS;

EID: 84870313030     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1217552109     Document Type: Article

References (36)

1. Camenisch G, et al. (2002) ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivo. J Biol Chem 277(19):17281-17290.
2. Mattijssen F, Kersten S (2012) Regulation of triglyceride metabolism by Angiopoietinlike proteins. Biochim Biophys Acta 1821(5):782-789.
3. Zhang CC, et al. (2006) Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells. Nat Med 12(2):240-245.
4. Musunuru K, et al. (2010) Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. N Engl J Med 363(23):2220-2227.
5. Koishi R, et al. (2002) Angptl3 regulates lipid metabolism in mice. Nat Genet 30(2): 151-157.
6. Romeo S, et al. (2009) Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. J Clin Invest 119(1):70-79.
7. Romeo S, et al. (2007) Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat Genet 39(4):513-516.
8. Köster A, et al. (2005) Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: Regulation of triglyceride metabolism. Endocrinology 146(11):4943-4950.
9. Desai U, et al. (2007) Lipid-lowering effects of anti-angiopoietin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout mice. Proc Natl Acad Sci USA 104(28):11766-11771.
10. Kersten S, et al. (2000) Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene. J Biol Chem 275(37): 28488-28493.
11. Sukonina V, Lookene A, Olivecrona T, Olivecrona G (2006) Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue. Proc Natl Acad Sci USA 103(46):17450-17455.
12. Ge H, et al. (2005) Differential regulation and properties of angiopoietin-like proteins 3 and 4. J Lipid Res 46(7):1484-1490.
13. Shimizugawa T, et al. (2002) ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J Biol Chem277(37):33742-33748.
14. Fujimoto K, Koishi R, Shimizugawa T, Ando Y (2006) Angptl3-null mice show low plasma lipid concentrations by enhanced lipoprotein lipase activity. Exp Anim 55(1): 27-34.
15. Shan L, et al. (2009) The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms. J Biol Chem 284(3):1419-1424.
16. Lee EC, et al. (2009) Identification of a new functional domain in angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) involved in binding and inhibition of lipoprotein lipase (LPL). J Biol Chem 284(20):13735-13745.
17. Ando Y, et al. (2003) A decreased expression of angiopoietin-like 3 is protective against atherosclerosis in apoE-deficient mice. J Lipid Res 44(6):1216-1223.
18. Jin W, et al. (2007) Hepatic proprotein convertases modulate HDL metabolism. Cell Metab 6(2):129-136.
19. Shimamura M, et al. (2007) Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase. Arterioscler Thromb Vasc Biol 27 (2):366-372.
20. Ono M, et al. (2003) Protein region important for regulation of lipid metabolism in angiopoietin-like 3 (ANGPTL3): ANGPTL3 is cleaved and activated in vivo. J Biol Chem 278(43):41804-41809.
21. Ren G, Kim JY, Smas CM (2012) Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism. Am J Physiol Endocrinol Metab 303(3):E334-E351.
22. Zhang R (2012) Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels. Biochem Biophys Res Commun 424(4):786-792.
23. Yin W, et al. (2009) Genetic variation in ANGPTL4 provides insights into protein processing and function. J Biol Chem 284(19):13213-13222.
24. Victor RG, et al. and Dallas Heart Study Investigators (2004) The Dallas Heart Study: A population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol 93(12):1473-1480.
25. Anonymous (1987) ARIC Manual of Operations: No 2, Cohort Component Procedures (ARIC Coordinating Center, School of Public Health, Univ of North Carolina, Chapel Hill).
26. Teslovich TM, et al. (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466(7307):707-713.
27. Robciuc MR, Tahvanainen E, Jauhiainen M, Ehnholm C (2010) Quantitation of serum angiopoietin-like proteins 3 and 4 in a Finnish population sample. J Lipid Res 51(4): 824-831.
28. Horton JD, Goldstein JL, Brown MS (2002) SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109(9): 1125-1131.
29. Repa JJ, et al. (2000) Regulation of mouse sterol regulatory element-binding protein- 1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev 14(22): 2819-2830.
30. Horton JD, Goldstein JL, Brown MS (2002) SREBPs: Transcriptional mediators of lipid homeostasis. Cold Spring Harb Symp Quant Biol 67:491-498.
31. Matsuda M, et al. (2001) SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation. Genes Dev 15(10):1206-1216.
32. Tang T, et al. (2010) A mouse knockout library for secreted and transmembrane proteins. Nat Biotechnol 28(7):749-755.
33. Blasius AL, et al. (2009) Mice with mutations of Dock7 have generalized hypopigmentation and white-spotting but show normal neurological function. Proc Natl Acad Sci USA 106(8):2706-2711.
34. Shaheen R, et al. (2011) Recessive mutations in DOCK6, encoding the guanidine nucleotide exchange factor DOCK6, lead to abnormal actin cytoskeleton organization and Adams-Oliver syndrome. Am J Hum Genet 89(2):328-333.
35. Romeo S, et al. (2008) Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 40(12):1461-1465.
36. Valenzuela DM, et al. (2003) High-throughput engineering of the mouse genome coupled with high-resolution expression analysis. Nat Biotechnol 21:652-659.